the changing of the hyperlipoproteinemia phenotypus iv to the phenotypus iib or iia under monotherapy with clofibrate or clofibrinic acid could not be avoided by the combination of clofibrate with m-inositolnicotinate .
C0020476
hyperlipoproteinemia
C0009002
clofibrate